MAP3K14 and chronic kidney disease: Since PTX3 is more sensitive than hs-CRP in distinguishing stages of DN, it holds promise as a more reliable biomarker for assessing kidney function and predicting the risk of chronic kidney disease (CKD) in diabetic patients [56].